MDM2 and cancer: In agreement with promoting tumor cell vitality (Figure 6E), PDLIM7 was shown to stabilizes MDM2 by interfering with its autoubiquitination resulting in reduced responsiveness toward CDK4/6-inhibition by PD03329921 in cancer cells (56,57).